UBS Group AG - DICE THERAPEUTICS INC ownership

DICE THERAPEUTICS INC's ticker is and the CUSIP is 23345J104. A total of 82 filers reported holding DICE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.20 and the average weighting 1.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of DICE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$19,712,234
+4161.9%
424,284
+2528.1%
0.01%
Q1 2023$462,526
+63.2%
16,144
+77.7%
0.00%
Q4 2022$283,483
+14074.2%
9,086
+7287.0%
0.00%
Q3 2022$2,000
-94.9%
123
-94.0%
0.00%
Q1 2022$39,000
-65.2%
2,059
-53.5%
0.00%
Q4 2021$112,0004,4310.00%
Other shareholders

There were no reported owners of DICE THERAPEUTICS INC in Q2 2022.

NameSharesValueWeighting ↓
View complete list of DICE THERAPEUTICS INC shareholders